U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07864519) titled 'Low-dose Imaging TechniquE in Breast MRI' on Sept. 29.
Brief Summary: The purpose of the study is to compare a low-dose contrast enhanced breast MRI (bMRI) protocol with a standard dose protocol, using a dual-dose injection technique. By assessing the conspicuity and enhancement of lesions detected during bMRI, the investigators hope to demonstrate that lower doses of contrast agent may be clinically feasible.
Study Start Date: Nov. 01
Study Type: INTERVENTIONAL
Condition:
Breast MRI
Intervention:
DRUG: Standard of care contrast agent, provided in split dose
Total dosage of the contrast agent provided is the same as for a clin...